Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Hamish J Farquhar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canterbury Arthritis Support Trust, Scholarship grant administered by University of Otago, Bannan Trust, Scholarship grant administered by University of Otago.
Abstract (Originalsprache)
Background
There is relatively little research regarding the frequency of rheumatoid arthritis (RA) in Canterbury and no previous studies comparing the mortality of RA in Aotearoa New Zealand to a general population.
Aims
To determine the incidence, prevalence and mortality of RA in Canterbury, Aotearoa New Zealand.
Methods
Clinical records of persons attending the Christchurch Hospital rheumatology service between 1 January 2006 and 31 December 2008 (Period 1) and between 1 January 2011 and 31 December 2013 (Period 2) were reviewed to identify individuals who met the 2010 American College of Rheumatology/European League Against Rheumatism RA classification criteria. Medical records for persons treated by private sector rheumatologists were also reviewed. The period prevalence and average annual incidence for each time period were calculated. Prevalence and incidence rates for the total population were age‐ and sex‐adjusted based on the usually resident population from the 2013 national Census. Standardised mortality ratios (SMRs) compared to the general population were calculated.
Results
The annual incidence was 24.40 per 100 000 (95% confidence interval (CI): 21.36–27.43) for Period 1 and 22.06 per 100 000 (95% CI: 19.32–24.81) for Period 2. The period prevalence was 442.65 per 100 000 (95% CI: 420.08–465.04) for Period 1 and 448.66 per 100 000 (95% CI: 427.31–470.01) for Period 2. The all‐cause SMR for individuals with incident RA was 1.25 (95% CI: 0.95–1.60). The SMR for all prevalent RA during Period 1 was 2.01 (95% CI: 1.85–2.19) and for Period 2 was 1.87 (95% CI: 1.69–2.06).
Conclusions
The frequency of RA in the Canterbury population is comparable to other regions. Mortality for all individuals with prevalent RA was approximately two times higher than the general population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
- Māori Indigenous Health Innovation Department, University of Otago Christchurch, Christchurch, New Zealand.
ORCID-Profile: Hamish J Farquhar, Lutz Beckert, Lisa K Stamp
Förderung
- Canterbury Arthritis Support Trust, Scholarship grant administered by University of Otago
- Bannan Trust, Scholarship grant administered by University of Otago
Zitieren
APA
Farquhar, H. J., Huria, T., Beckert, L., Frampton, C. M. A., Haslett, J., & Stamp, L. K. (2025). Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand. Internal Medicine Journal. https://doi.org/10.1111/imj.70068
Vancouver
Farquhar HJ, Huria T, Beckert L, Frampton CMA, Haslett J, Stamp LK. Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand. Internal Medicine Journal. 2025. doi:10.1111/imj.70068
BibTeX
@article{Farquhar2025,
author = {Farquhar, Hamish J and Huria, Tania and Beckert, Lutz and Frampton, Christopher M A and Haslett, Janine and Stamp, Lisa K},
title = {Incidence, prevalence and mortality of rheumatoid arthritis in Canterbury, Aotearoa New Zealand},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70068}
}
EUVIMED